286 related articles for article (PubMed ID: 7491686)
1. Intrathymic injection of alloantigen may lead to hyperacute rejection and prolonged graft survival of heart allografts in the rat.
de Bruin RW; van Rossum TJ; Scheringa M; Bonthuis F; IJzermans JN; Marquet RL
Transplantation; 1995 Nov; 60(9):1061-3. PubMed ID: 7491686
[No Abstract] [Full Text] [Related]
2. Duration of donor-specific tolerance after intrathymic administration of alloantigen.
Arima T; Nakafusa Y; Goss JA; Walp LA; Yu S; Flye MW
Transplant Proc; 1995 Feb; 27(1):136-7. PubMed ID: 7878912
[No Abstract] [Full Text] [Related]
3. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
Nakafusa Y; Arima T; Goss JA; Flye MW
Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
[No Abstract] [Full Text] [Related]
4. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
[No Abstract] [Full Text] [Related]
5. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
[TBL] [Abstract][Full Text] [Related]
6. Tolerance induction to cardiac allografts by sequential intrathymic inoculation of disparate alloantigens.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1996 Jun; 28(3):1283-4. PubMed ID: 8658661
[No Abstract] [Full Text] [Related]
7. The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts.
Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
Transplantation; 1995 Feb; 59(4):590-7. PubMed ID: 7878763
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific cardiac allograft tolerance without immunosuppression after intrathymic injection of donor alloantigen.
Goss JA; Nakafusa Y; Flye MW
Transplant Proc; 1992 Dec; 24(6):2879-80. PubMed ID: 1465981
[No Abstract] [Full Text] [Related]
9. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
[No Abstract] [Full Text] [Related]
10. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
Shimomura K; Hardy MA; Oluwole SF
Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
[No Abstract] [Full Text] [Related]
11. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4.
Hancock WW; Sayegh MH; Carpenter CB
Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074
[No Abstract] [Full Text] [Related]
13. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
Xia W; Sayegh MH; Kirkman RL
Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
[No Abstract] [Full Text] [Related]
14. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Kahan BD
Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
[No Abstract] [Full Text] [Related]
15. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
[No Abstract] [Full Text] [Related]
16. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of hepatic and cardiac allografts by i.v. injection of donor spleen cells following splenectomy in rats: possible mechanisms involved in tolerance induced by intraportal injection of donor antigens.
Nagano H; Monden M; Gotoh M; Tanigawa T; Nakano Y; Tono T; Mori T
Transplant Proc; 1993 Feb; 25(1 Pt 1):352-3. PubMed ID: 8438331
[No Abstract] [Full Text] [Related]
18. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A.
Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H
Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915
[No Abstract] [Full Text] [Related]
19. Evidence for the role of host antigen-presenting cells in the induction of specific unresponsiveness to allografts by intrathymic inoculation of allopeptides.
Oluwole SF; Jin MX; Chowdhury NC; Engelstad K; Ohajekwe OA; Hardy MA
Transplant Proc; 1995 Feb; 27(1):132-3. PubMed ID: 7878898
[No Abstract] [Full Text] [Related]
20. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
Shen Z; Mohiuddin M; DiSesa VJ
Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
